Seigne J - Search Results

1

Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro.

Li J, Hu SX, Perng GS, Zhou Y, Xu K, Zhang C, Seigne J, Benedict WF, Xu HJ. Li J, et al. Among authors: seigne j. Oncogene. 1996 Dec 5;13(11):2379-86. Oncogene. 1996. PMID: 8957079

2

Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.

Xu HJ, Zhou Y, Seigne J, Perng GS, Mixon M, Zhang C, Li J, Benedict WF, Hu SX. Xu HJ, et al. Among authors: seigne j. Cancer Res. 1996 May 15;56(10):2245-9. Cancer Res. 1996. PMID: 8625292

3

Characteristics of invasive bladder cancers: histological and molecular markers.

Liebert M, Seigne J. Liebert M, et al. Among authors: seigne j. Semin Urol Oncol. 1996 May;14(2):62-72. Semin Urol Oncol. 1996. PMID: 8734733 Review.

4

B7-1 gene-modified autologous tumor-cell vaccines for renal-cell carcinoma.

Antonia SJ, Seigne JD. Antonia SJ, et al. Among authors: seigne jd. World J Urol. 2000 Apr;18(2):157-63. doi: 10.1007/s003450050190. World J Urol. 2000. PMID: 10854153 Review.

5

Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma.

Antonia SJ, Seigne J, Diaz J, Muro-Cacho C, Extermann M, Farmelo MJ, Friberg M, Alsarraj M, Mahany JJ, Pow-Sang J, Cantor A, Janssen W. Antonia SJ, et al. Among authors: seigne j. J Urol. 2002 May;167(5):1995-2000. J Urol. 2002. PMID: 11956426 Clinical Trial.

6

Osteitis pubis as a complication of prostate cryotherapy.

Seigne JD, Pisters LL, von Eschenbach AC. Seigne JD, et al. J Urol. 1996 Jul;156(1):182. J Urol. 1996. PMID: 8648793 No abstract available.

7

A GM-CSF/CD40L producing cell augments anti-tumor T cell responses.

Dessureault S, Alsarraj M, McCarthy S, Hunter T, Noyes D, Lee D, Harkins J, Seigne J, Jennings R, Antonia SJ. Dessureault S, et al. Among authors: seigne j. J Surg Res. 2005 May 15;125(2):173-81. doi: 10.1016/j.jss.2004.11.036. Epub 2005 Jan 28. J Surg Res. 2005. PMID: 15854671

8

Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Mora LB, et al. Among authors: seigne j. Cancer Res. 2002 Nov 15;62(22):6659-66. Cancer Res. 2002. PMID: 12438264

9

Clinicopathological correlates of Gli1 expression in a population-based cohort of patients with newly diagnosed bladder cancer.

Sverrisson EF, Zens MS, Fei DL, Andrews A, Schned A, Robbins D, Kelsey KT, Li H, DiRenzo J, Karagas MR, Seigne JD. Sverrisson EF, et al. Among authors: seigne jd. Urol Oncol. 2014 Jul;32(5):539-45. doi: 10.1016/j.urolonc.2014.03.006. Epub 2014 May 22. Urol Oncol. 2014. PMID: 24856810 Free PMC article.

10

Surgical management of bladder cancer in 2003.

Wade M, Seigne JD. Wade M, et al. Expert Rev Anticancer Ther. 2003 Dec;3(6):781-92. doi: 10.1586/14737140.3.6.781. Expert Rev Anticancer Ther. 2003. PMID: 14686700 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page